Potential implications of using locally validated risk factors for drug-resistant pathogens in patients with community-acquired pneumonia in US hospitals: A cross-sectional study.
Hamlet GasoyanAbhishek DeshpandePeter B ImreyNing GuoBenjamin G MittmanMichael B RothbergPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Future guidelines should explicitly define the optimal trade-off between adequate coverage for resistant organisms and ESA use.